Back to search

Boston University

Gene therapy as a viable therapeutic approach for Parkinson's disease

Abstract

dc:description.abstract

Parkinson’s Disease (PD) is a neurological disorder affecting the basal ganglia in which the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) manifests as a complex array of motor and non-motor symptoms. Due to the lack of treatment for preventing the neurodegenerative process of PD, the only available therapy options involve managing the clinical symptoms resulting from dopamine (DA) depletion in the basal ganglia. The most widely implemented treatment is the pharmacological agent L-DOPA which serves as the precursor to dopamine. Although L-DOPA administration is initially effective in improving motor function and patient life quality, its therapeutic effect diminishes as PD pathology progressively worsens over time and side effects such as L-DOPA induced dyskinesia become apparent. Researchers are now seeking to alleviate the symptoms of PD on a molecular basis with gene therapy in which the three therapeutic strategies target specific genes involved in either increasing dopamine production, regulating the pathways of the basal ganglia, or protecting dopaminergic neurons of the nigrostriatal pathway. Current research is focused on investigating the efficacy and overall safety of gene therapy through delivery of the genes responsible for aromatic L-acid decarboxylase (AADC), glutamic acid decarboxylase (GAD), glial cell derived neurotrophic factor (GDNF), and neurturin (NRTN). Although these methods of gene therapy are relatively new and still developing, they present a promising direction for PD treatment. In this review, the various gene therapy strategies designed for improving parkinsonism are evaluated for safety and efficacy.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chammas, Chantal
Advisors dc:contributor.advisor
  • Soghomonian, Jean-Jacques
  • Zhang, Kunzhong

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/36248

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chammas, Chantal. Gene therapy as a viable therapeutic approach for Parkinson's disease. masters thesis, Boston University, 2019. https://hdl.handle.net/2144/36248